Navigation Links
An 'attractive' man-machine interface
Date:1/8/2008

Researchers at Childrens Hospital Boston have developed a new nanobiotechnology that enables magnetic control of events at the cellular level. They describe the technology, which could lead to finely-tuned but noninvasive treatments for disease, in the January issue of Nature Nanotechnology (published online January 3).

Don Ingber, MD, PhD, and Robert Mannix, PhD, of Childrens program in Vascular Biology, in collaboration with Mara Prentiss, PhD, a physicist at Harvard University, devised a way to get tiny beads 30 nanometers (billionths of a meter) in diameter to bind to receptor molecules on the cell surface. When exposed to a magnetic field, the beads themselves become magnets, and pull together through magnetic attraction. This pull drags the cells receptors into large clusters, mimicking what happens when drugs or other molecules bind to them. This clustering, in turn, activates the receptors, triggering a cascade of biochemical signals that influence different cell functions.

The technology could lead to non-invasive ways of controlling drug release or physiologic processes such as heart rhythms and muscle contractions, says Ingber, the studys senior investigator. More importantly, it represents the first time magnetism has been used to harness specific cellular signaling systems normally used by hormones or other natural molecules.

This technology allows us to control the behavior of living cells through magnetic forces rather than chemicals or hormones, says Ingber. It may provide a new way to interface with machines or computers in the future, opening up entirely new ways of controlling drug delivery, or making detectors that have living cells as component parts. Weve harnessed a biological control system, but we can control it at will, using magnetic forces.

In a demonstration involving mast cells (a kind of cell in the immune system), Ingber and Mannix showed that the beads, when bound to cell receptors and expo
'/>"/>

Contact: James Newton
James.Newton@childrens.harvard.edu
617-919-3110
Children's Hospital Boston
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Like father, like son: Attractiveness is hereditary
2. IdentiPHI Introduces Biometric Authentication Solution for Citrix Web Interface Environments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2015)... , April 13, 2015  higi, a leading cloud-based ... to more fully engage with their communities around health ... privacy protected and secure API.  ... the most accessible, affordable, and convenient vehicle to receive ... The API will allow higi,s ...
(Date:4/9/2015)... , April 9, 2015 Synaptics Inc. (NASDAQ: ... solutions, announced today that it will report financial results ... April 23, 2015, after the close of market. The ... and investors at 2:00 p.m. PT (5:00 p.m. ET), ... To participate on the live call, analysts and ...
(Date:4/6/2015)... OXFORD, Conn. , Apr. 6, 2015 /PRNewswire/ ... the "Company"), a biometric authentication company focused on ... it has filed provisional patent 62/143028 for ... CLOSE-PROXIMITY COMMUNICATIONS AND ENERGY TRANSFER  NXT-ID introduces ... wireless payments. This patent surrounds the use of ...
Breaking Biology News(10 mins):higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3Synaptics to Report Third Quarter Results on April 23 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4
... to DNA and then cut these "DNA wires" into ... for future computers. , Findings are detailed in a ... the American Chemical Society. The paper was written by ... an assistant professor of biomedical engineering and chemistry at ...
... Ed : Don't miss out the cool movies, link at ... School of Medicine researchers have found a way to exercise ... jump, beat their wings, and fly on command by triggering ... the insects' central nervous systems, according to a new report ...
... Southampton are continuing their pioneering research into diseases such as ... known as prions, thanks to a £300,000 grant from the ... deaths from confirmed or probable variant CJD (vCJD) in the ... by eating food contaminated with prions that is also responsible ...
Cached Biology News:Purdue researchers use enzyme to clip 'DNA wires' 2Purdue researchers use enzyme to clip 'DNA wires' 3Remote control flies? Fly behavior controlled by laser light 2Remote control flies? Fly behavior controlled by laser light 3
(Date:5/21/2015)... 21, 2015 uBiome, the leading ... partnership with PicnicHealth, a healthcare company that collects ... with Inflammatory Bowel Disease (IBD) will receive a ... uBiome research kit. Both companies were funded by ... , For more information on this partnership and ...
(Date:5/21/2015)... 2015  CytRx Corporation (NASDAQ: CYTR ), ... oncology, today announced positive updated results from its ... the treatment of unresectable glioblastoma multiforme (GBM), a ... trial is designed to investigate the preliminary efficacy ... have progressed following prior treatment with surgery, radiation ...
(Date:5/21/2015)... 2015 Tunnell Consulting, Inc. ... as senior statistician and Principal, a position to which ... the management and analysis of complex and large data ... , “We’re delighted to have Julia join the Tunnell ... said Dr. Philippe Cini, Group Vice President and leader ...
(Date:5/20/2015)... , May 20, 2015  Select Medical ... the Federal Trade Commission granted early termination of ... Improvements Act of 1976, as amended, applicable to ... Acquisition Corporation, a joint venture that Select has ... As previously announced, MJ Acquisition Corporation ...
Breaking Biology Technology:uBiome Partners with PicnicHealth 2uBiome Partners with PicnicHealth 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2Select Medical Corporation's Proposed Acquisition of Concentra Inc. through Joint Venture with Welsh Carson Receives Antitrust Clearance 2
... Fla., Aug. 21 Bioheart, Inc.,(Nasdaq: BHRT ... and,biologics that help monitor, diagnose and treat heart ... $1 million unsecured,loan from Rogers Telecommunications Limited. This ... or Bioheart,s repayment of its loan from BlueCrest,Capital. ...
... to Life Science ... ... the region,s,driving force of innovation and economic development, will soon launch ... provides Michigan,s life science start-ups with valuable,research and technical equipment, donated ...
... GlaxoSmithKline (NYSE:,GSK) today announced that, beginning ... educational and charitable grants provided to US,health-related ... a quarterly,basis and will include grants provided ... care organizations, professional,associations, patient advocacy groups, and ...
Cached Biology Technology:Bioheart, Inc. Announces Additional Funding Support 2Bioheart, Inc. Announces Additional Funding Support 3Bioheart, Inc. Announces Additional Funding Support 4Michigan Innovation Equipment Depot Launches Next Phase of Distribution 2GlaxoSmithKline To Post Quarterly US Grants Report 2
Rabbit polyclonal to VPAC2 ( Abpromise for all tested applications). entrezGeneID: 7434 SwissProtID: P41587...
Mouse monoclonal [4A2.2] to SLC6A4 ( Abpromise for all tested applications). entrezGeneID: 6532 SwissProtID: P31645...
Anti-DNA Polymerase a, Human Description: 50 l Research Focus: cancer & cell proliferation Storage: 4C Shipping Temperature: 4C...
Monoclonal Anti-Cystatin A tissue culture supernatant Solution containing 15 mM sodium azide human cystatin A ...
Biology Products: